An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
Article purchase
Temporarily unavailable
References
1
El Baou, C, John, A, Lewer, D, Mandy, W, McKechnie, DGJ, Petersen, I, et al.Life expectancy and years of life lost for adults with diagnosed ADHD in the UK: matched cohort study. Br J Psychiatry2025; 226: 1–8.CrossRefGoogle Scholar
Khan, MU, Hasan, SS.Socioeconomic status and prescribing of ADHD medications: a study of ICB-level data in England. BMJ Ment Health2025; 28: e301384.10.1136/bmjment-2024-301384CrossRefGoogle ScholarPubMed
4
Elliott, J, Johnston, A, Husereau, D, Kelly, SE, Eagles, C, Charach, A, et al.Pharmacologic treatment of attention deficit hyperactivity disorder in adults: a systematic review and network meta-analysis. PLoS One2020; 15: e0240584.10.1371/journal.pone.0240584CrossRefGoogle ScholarPubMed
5
Tadrous, M, Shakeri, A, Chu, C, Watt, J, Mamdani, MM, Juurlink, DN, et al.Assessment of stimulant use and cardiovascular event risks among older adults. JAMA Netw Open2021; 4: e2130795.10.1001/jamanetworkopen.2021.30795CrossRefGoogle ScholarPubMed
6
Zhang, L, Li, L, Andell, P, Garcia-Argibay, M, Quinn, PD, D’Onofrio, BM, et al.Attention-deficit/hyperactivity disorder medications and long-term risk of cardiovascular diseases. JAMA Psychiatry2024; 81: 178.CrossRefGoogle ScholarPubMed
7
Liang, EF, Lim, SZ, Tam, WW, Ho, CS, Zhang, MW, McIntyre, RS.The effect of methylphenidate and atomoxetine on heart rate and systolic blood pressure in young people and adults with attention-deficit hyperactivity disorder (ADHD): systematic review, meta-analysis, and meta-regression. Int J Environ Res Publ Health2018; 15: 1789.10.3390/ijerph15081789CrossRefGoogle Scholar
8
Curtin, K, Fleckenstein, AE, Keeshin, BR, Yurgelun-Todd, DA, Renshaw, PF, Smith, KR, et al.Increased risk of diseases of the basal ganglia and cerebellum in patients with a history of attention-deficit/hyperactivity disorder. Neuropsychopharmacology2018; 43: 2548.10.1038/s41386-018-0207-5CrossRefGoogle ScholarPubMed
9
Vasiliadis, HM, Lunghi, C, Rahme, E, Rochette, L, Gignac, M, Massamba, V, et al.ADHD medications use and risk of mortality and unintentional injuries: a population-based cohort study. Transl Psychiatry2024; 14: 128.CrossRefGoogle ScholarPubMed
eLetters
No eLetters have been published for this article.